HuGE Literature Finder
Records 1-29
|
RAS Pathway Mutation Patterns in Patients With Juvenile Myelomonocytic Leukemia: A Developing Country Single-center Experience.
Clinical lymphoma, myeloma & leukemia 2020 Feb . Hamdy Nayera, Bokhary Hossam, Elsayed Amr, Hozayn Walaa, Soliman Sonya, Salem Sherine, Alsheshtawi Khaled, Abdalla Amr, Hafez Hanafy, Hammad Mahmo |
|
Myeloid malignancies with isolated 7q deletion can be further characterized by their accompanying molecular mutations.
Genes, chromosomes & cancer 2019 Apr . Hartmann Luise, Haferlach Claudia, Meggendorfer Manja, Kern Wolfgang, Haferlach Torsten, Stengel An |
|
Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome.
Blood cancer journal 2018 Apr 8 (4): 39. Hou Hsin-An, Tsai Cheng-Hong, Lin Chien-Chin, Chou Wen-Chien, Kuo Yuan-Yeh, Liu Chieh-Yu, Tseng Mei-Hsuan, Peng Yen-Ling, Liu Ming-Chih, Liu Chia-Wen, Liao Xiu-Wen, Lin Liang-In, Yao Ming, Tang Jih-Luh, Tien Hwei-Fa |
|
Prognostic Role of Gene Mutations in Chronic Myelomonocytic Leukemia Patients Treated With Hypomethylating Agents.
EBioMedicine 2018 Apr . Duchmann Matthieu, Yalniz Fevzi F, Sanna Alessandro, Sallman David, Coombs Catherine C, Renneville Aline, Kosmider Olivier, Braun Thorsten, Platzbecker Uwe, Willems Lise, Adès Lionel, Fontenay Michaela, Rampal Raajit, Padron Eric, Droin Nathalie, Preudhomme Claude, Santini Valeria, Patnaik Mrinal M, Fenaux Pierre, Solary Eric, Itzykson Rapha |
|
Determination of CEBPA mutations by next generation sequencing in pediatric acute leukemia.
Bratislavske lekarske listy 2018 119 (6): 366-372. Akin D F, Oner D A, Kurekci E, Akar |
|
The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions.
Nature medicine 2017 Dec . Bolouri Hamid, Farrar Jason E, Triche Timothy, Ries Rhonda E, Lim Emilia L, Alonzo Todd A, Ma Yussanne, Moore Richard, Mungall Andrew J, Marra Marco A, Zhang Jinghui, Ma Xiaotu, Liu Yu, Liu Yanling, Auvil Jaime M Guidry, Davidsen Tanja M, Gesuwan Patee, Hermida Leandro C, Salhia Bodour, Capone Stephen, Ramsingh Giridharan, Zwaan Christian Michel, Noort Sanne, Piccolo Stephen R, Kolb E Anders, Gamis Alan S, Smith Malcolm A, Gerhard Daniela S, Meshinchi Sohe |
|
Targeted next-generation sequencing identifies clinically relevant mutations in patients with chronic neutrophilic leukemia at diagnosis and blast crisis.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2017 Jul . Langabeer S E, Haslam K, Kelly J, Quinn J, Morrell R, Conneally |
|
Next-generation sequencing in systemic mastocytosis: Derivation of a mutation-augmented clinical prognostic model for survival.
American journal of hematology 2016 May . Pardanani Animesh, Lasho Terra, Elala Yoseph, Wassie Emnet, Finke Christy, Reichard Kaaren K, Chen Dong, Hanson Curtis A, Ketterling Rhett P, Tefferi Ayal |
|
Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2016 May . Wang Sa A, Tam Wayne, Tsai Albert G, Arber Daniel A, Hasserjian Robert P, Geyer Julia T, George Tracy I, Czuchlewski David R, Foucar Kathryn, Rogers Heesun J, Hsi Eric D, Bryan Rea B, Bagg Adam, Dal Cin Paola, Zhao Chong, Kelley Todd W, Verstovsek Srdan, Bueso-Ramos Carlos, Orazi Attil |
|
Incidences and Prognostic Impact of c-KIT, WT1, CEBPA, and CBL Mutations, and Mutations Associated With Epigenetic Modification in Core Binding Factor Acute Myeloid Leukemia: A Multicenter Study in a Korean Population.
Annals of laboratory medicine 2015 May 35 (3): 288-97. Park Sang Hyuk, Lee Hyun Ji, Kim In-Suk, Kang Jeong-Eun, Lee Eun Yup, Kim Hyeoung-Joon, Kim Yeo-Kyeoung, Won Jong-Ho, Bang Soo Mee, Kim Hawk, Song Moo-Kon, Chung Joo Seop, Shin Ho-J |
|
Next-generation sequencing of acute myeloid leukemia identifies the significance of TP53, U2AF1, ASXL1, and TET2 mutations.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2015 May 28 (5): 706-14. Ohgami Robert S, Ma Lisa, Merker Jason D, Gotlib Jason R, Schrijver Iris, Zehnder James L, Arber Daniel |
|
CALR mutation screening in pediatric primary myelofibrosis.
Pediatric blood & cancer 2014 Dec 61 (12): 2256-62. An Wenbin, Wan Yang, Guo Ye, Chen Xiaojuan, Ren Yuanyuan, Zhang Jingliao, Chang Lixian, Wei Wei, Zhang Peihong, Zhu Xiaof |
|
High number of additional genetic lesions in acute myeloid leukemia with t(8;21)/RUNX1-RUNX1T1: frequency and impact on clinical outcome.
Leukemia 2014 Jul 28 (7): 1449-58. Krauth M-T, Eder C, Alpermann T, Bacher U, Nadarajah N, Kern W, Haferlach C, Haferlach T, Schnittger |
|
TET2 gene mutation is unfavorable prognostic factor in cytogenetically normal acute myeloid leukemia patients with NPM1+ and FLT3-ITD - mutations.
International journal of hematology 2014 Jul 100 (1): 96-104. Tian Xiaopeng, Xu Yang, Yin Jia, Tian Hong, Chen Suning, Wu Depei, Sun Aini |
|
Mutations and prognosis in primary myelofibrosis.
Leukemia 2013 Sep 27 (9): 1861-9. Vannucchi A M, Lasho T L, Guglielmelli P, Biamonte F, Pardanani A, Pereira A, Finke C, Score J, Gangat N, Mannarelli C, Ketterling R P, Rotunno G, Knudson R A, Susini M C, Laborde R R, Spolverini A, Pancrazzi A, Pieri L, Manfredini R, Tagliafico E, Zini R, Jones A, Zoi K, Reiter A, Duncombe A, Pietra D, Rumi E, Cervantes F, Barosi G, Cazzola M, Cross N C P, Tefferi |
|
SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations.
Leukemia 2013 Sep 27 (9): 1852-60. Meggendorfer M, Bacher U, Alpermann T, Haferlach C, Kern W, Gambacorti-Passerini C, Haferlach T, Schnittger |
|
The importance of relative mutant level for evaluating impact on outcome of KIT, FLT3 and CBL mutations in core-binding factor acute myeloid leukemia.
Leukemia 2013 Sep 27 (9): 1891-901. Allen C, Hills R K, Lamb K, Evans C, Tinsley S, Sellar R, O'Brien M, Yin J L, Burnett A K, Linch D C, Gale R |
|
Prognostic score including gene mutations in chronic myelomonocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013 Jul 31 (19): 2428-36. Itzykson Raphaël, Kosmider Olivier, Renneville Aline, Gelsi-Boyer Véronique, Meggendorfer Manja, Morabito Margot, Berthon Céline, Adès Lionel, Fenaux Pierre, Beyne-Rauzy Odile, Vey Norbert, Braun Thorsten, Haferlach Torsten, Dreyfus François, Cross Nicholas C P, Preudhomme Claude, Bernard Olivier A, Fontenay Michaela, Vainchenker William, Schnittger Susanne, Birnbaum Daniel, Droin Nathalie, Solary Er |
|
[Clinical significance of common leukemia gene mutations in patients with acute promyelocytic leukemia].
Zhongguo shi yan xue ye xue za zhi / Zhongguo bing li sheng li xue hui = Journal of experimental hematology / Chinese Association of Pathophysiology 2013 Jan 21 (1): 1. Yin J, Sun AN, Tian XP, Tian H, Wang RX, Yang Z, Wang XL, Wu DP, Qiu HY, Pan JL, Cen JN, Liang JY, Chen SN |
|
EZH2 mutations are related to low blast percentage in bone marrow and -7/del(7q) in de novo acute myeloid leukemia.
PloS one 2013 8 (4): e61341. Wang Xiuli, Dai Haiping, Wang Qian, Wang Qinrong, Xu Yang, Wang Ying, Sun Aining, Ruan Jia, Chen Suning, Wu Dep |
|
Use of CBL exon 8 and 9 mutations in diagnosis of myeloproliferative neoplasms and myelodysplastic/myeloproliferative disorders: an analysis of 636 cases.
Haematologica 2012 Dec 97 (12): 1890-4. Schnittger Susanne, Bacher Ulrike, Alpermann Tamara, Reiter Andreas, Ulke Madlen, Dicker Frank, Eder Christiane, Kohlmann Alexander, Grossmann Vera, Kowarsch Andreas, Kern Wolfgang, Haferlach Claudia, Haferlach Torst |
|
Clinical significance of genetic aberrations in secondary acute myeloid leukemia.
American journal of hematology 2012 Nov 87 (11): 1010-6. Milosevic Jelena D, Puda Ana, Malcovati Luca, Berg Tiina, Hofbauer Michael, Stukalov Alexey, Klampfl Thorsten, Harutyunyan Ashot S, Gisslinger Heinz, Gisslinger Bettina, Burjanivova Tatiana, Rumi Elisa, Pietra Daniela, Elena Chiara, Vannucchi Alessandro M, Doubek Michael, Dvorakova Dana, Robesova Blanka, Wieser Rotraud, Koller Elisabeth, Suvajdzic Nada, Tomin Dragica, Tosic Natasa, Colinge Jacques, Racil Zdenek, Steurer Michael, Pavlovic Sonja, Cazzola Mario, Kralovics Robe |
|
Molecular analyses of 15,542 patients with suspected BCR-ABL1-negative myeloproliferative disorders allow to develop a stepwise diagnostic workflow.
Haematologica 2012 Oct 97 (10): 1582-5. Schnittger Susanne, Bacher Ulrike, Eder Christiane, Dicker Frank, Alpermann Tamara, Grossmann Vera, Kohlmann Alexander, Kern Wolfgang, Haferlach Claudia, Haferlach Torst |
|
SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML).
Blood 2012 Oct 120 (15): 3080-8. Meggendorfer Manja, Roller Andreas, Haferlach Torsten, Eder Christiane, Dicker Frank, Grossmann Vera, Kohlmann Alexander, Alpermann Tamara, Yoshida Kenichi, Ogawa Seishi, Koeffler H Phillip, Kern Wolfgang, Haferlach Claudia, Schnittger Susan |
|
Mutation analysis of ASXL1, CBL, DNMT3A, IDH1, IDH2, JAK2, MPL, NF1, SF3B1, SUZ12, and TET2 in myeloproliferative neoplasms.
Genes, chromosomes & cancer 2012 Aug 51 (8): 743-55. Brecqueville Mandy, Rey Jérôme, Bertucci François, Coppin Emilie, Finetti Pascal, Carbuccia Nadine, Cervera Nathalie, Gelsi-Boyer Véronique, Arnoulet Christine, Gisserot Olivier, Verrot Denis, Slama Borhane, Vey Norbert, Mozziconacci Marie-Joelle, Birnbaum Daniel, Murati An |
|
Rapid Screening of ASXL1, IDH1, IDH2, and c-CBL Mutations in de Novo Acute Myeloid Leukemia by High-Resolution Melting.
The Journal of molecular diagnostics : JMD 2012 Aug . Ibañez M, Such E, Cervera J, Luna I, Gomez-Seguí I, Lopez-Pavía M, Dolz S, Barragan E, Fuster O, Llop M, Rodriguez-Veiga R, Avaria A, Oltra S, Leonor Senent M, Moscardó F, Montesinos P, Martinez-Cuadrón D, Martín G, Sanz MA |
|
Gene mutations in the Ras pathway and the prognostic implication in Korean patients with juvenile myelomonocytic leukemia.
Annals of hematology 2012 Apr 91 (4): 511-7. Park Hyung-Doo, Lee Soo Hyun, Sung Ki Woong, Koo Hong Hoe, Jung Nak Gyun, Cho Bin, Kim Hak Ki, Park In-Ae, Lee Ki-O, Ki Chang-Seok, Kim Sun-Hee, Yoo Keon Hee, Kim Hee-J |
|
EZH2 mutational status predicts poor survival in myelofibrosis.
Blood 2011 Nov 118 (19): 5227-34. Guglielmelli Paola, Biamonte Flavia, Score Joannah, Hidalgo-Curtis Claire, Cervantes Francisco, Maffioli Margherita, Fanelli Tiziana, Ernst Thomas, Winkelman Nils, Jones Amy V, Zoi Katerina, Reiter Andreas, Duncombe Andrew, Villani Laura, Bosi Alberto, Barosi Giovanni, Cross Nicholas C P, Vannucchi Alessandro |
|
CBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia.
Blood 2011 May 117 (21): e198-206. Makishima Hideki, Jankowska Anna M, McDevitt Michael A, O'Keefe Christine, Dujardin Simon, Cazzolli Heather, Przychodzen Bartlomiej, Prince Courtney, Nicoll John, Siddaiah Harish, Shaik Mohammed, Szpurka Hadrian, Hsi Eric, Advani Anjali, Paquette Ronald, Maciejewski Jaroslaw |
- Page last reviewed:Oct 1, 2020
- Page last updated:Mar 03, 2021
- Content source: